Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 49
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Can Vet J ; 62(4): 384-388, 2021 04.
Artigo em Inglês | MEDLINE | ID: mdl-33867551

RESUMO

The types of submissions presented for forensic purposes to a private specialty practice in veterinary diagnostic pathology over a 10-year period are reviewed in this article. Records of forensic submissions were analyzed for diagnostic conclusions which were then categorized for a potential breach of law. In 34 of 66 total submissions, death was due to a cause other than potential violation of law. In the remaining 32 submissions, good postmortem examination and description of findings was sufficient to provide the police and courts with the information required for their investigations. The findings are discussed with a view to dispelling the reluctance of many veterinary clinicians to accept forensic cases.


Soumissions médico-légales dans un cabinet de pathologie diagnostique : un examen sur 10 ans. Les types de soumissions présentées à des fins médico-légales à une pratique privée spécialisée en pathologie diagnostique vétérinaire sur une période de 10 ans sont examinées dans cet article. Les dossiers des soumissions médico-légales ont été analysés pour des conclusions diagnostiques qui ont ensuite été catégorisées pour une violation potentielle de la loi. Dans 34 des 66 soumissions totales, le décès était dû à une cause autre qu'une violation potentielle de la loi. Dans les 32 soumissions restantes, un bon examen post-mortem et une bonne description des conclusions étaient suffisants pour fournir à la police et aux tribunaux les informations nécessaires à leurs enquêtes. Les résultats sont discutés dans le but de dissiper la réticence de nombreux cliniciens vétérinaires à accepter les cas médico-légaux.(Traduit par Dr Serge Messier).


Assuntos
Medicina Legal , Patologia Veterinária , Animais , Autopsia/veterinária
2.
Burns ; 46(7): 1632-1640, 2020 11.
Artigo em Inglês | MEDLINE | ID: mdl-32381448

RESUMO

PURPOSE: A variety of silver-based antimicrobial dressings are available on the market and are commonly used to prevent infection. Such prophylaxis is particularly important in treating burns, yet there is a paucity of evidence confirming the efficacy of commercially available dressingsin vivo. We describe here an in vivo porcine model of burns, which we use to test the antimicrobial efficacy of three common wound dressings and a control. PROCEDURES: Domestic Yorkshire-cross pigs were medicated for pain management before inflicting burns with a heated brass rod. The wounds were artificially challenged with a mixture of two pathogens commonly associated with burn wound infection:Staphylococcus aureus and Pseudomonas aeruginosa. The following dressing materials were sutured in place: gauze, nanocrystalline silver, silver-plated nylon, and polyethylene/polyester coated with high-oxidation silver salts. After 1 and 3 days, the wounds were assessed for erythema, swelling, and re-epithelialization, tissue was biopsied to determine the recovery of the challenge microorganisms, and histology was performed. We also examined the number of microorganisms present on the dressings themselves. RESULTS: Histology indicated that 30 s was sufficient to produce burns extending into the deep dermal layer. After 3 days, nanocrystalline silver and silver-plated nylon led to slightly reduced swelling relative to simple gauze, although none of the dressings significantly affected erythema or wound re-epithelialization. All the dressings led to decreased recovery of the challenge organisms from the burn tissue, relative to simple gauze. However, the magnitude of the reduction was greatest for nanocrystalline silver (log10 reduction = 4-5); additionally, only nanocrystalline silver gave a statistically significant decrease (P = 0.02). Notably, the antimicrobial effect for all dressings was reduced by Day 3 relative to Day 1. Similar trends were observed for microbial retention on the dressings themselves. CONCLUSION: Nanocrystalline silver-based wound dressings generally outperformed silver-plated nylon and high-oxidation silver salts in thisin vivo model of burn wounds. Relative to prophylactic use, it may be advisable to change the dressings more frequently when treating an infected wound.


Assuntos
Anti-Infecciosos , Bandagens , Queimaduras , Prata/uso terapêutico , Infecção dos Ferimentos , Animais , Anti-Infecciosos/uso terapêutico , Queimaduras/complicações , Queimaduras/terapia , Nylons , Poliésteres , Polietileno , Sais , Suínos , Infecção dos Ferimentos/tratamento farmacológico , Infecção dos Ferimentos/prevenção & controle
3.
Vet Pathol ; 56(3): 444-451, 2019 05.
Artigo em Inglês | MEDLINE | ID: mdl-30722758

RESUMO

Dismembered cats ( Felis catus) have been found in North American schoolyards, parks, walkways, or lawns and sometimes result in local media attention. When a member of the public encounters these cats, they commonly report finding either the cranial or caudal half of a cat in a prominent location. Such findings cause public consternation and pose difficulties to investigators in identifying whether animal abuse has occurred and whether to concentrate resources on the investigation. This report describes necropsy results from 53 cats involved in such instances in the cities of Edmonton and St. Albert, Canada, from 2007 to 2016. We evaluated these results in relation to 2 hypotheses: that the dismembered cats were the result of human activity, or predation and scavenging by coyotes ( Canis latrans). The main postmortem features were canine tooth wounds in the neck accompanied by tearing of the subcutaneous structures, skin avulsion, broken claws, and removal of internal organs with the colon and intestine attached to and trailing from the carcass. Based on the nature of the lesions, along with other circumstances of the deaths of the cats in this study, we concluded that these dismembered cat remains resulted from coyote predation on living cats and scavenging of the bodies of cats that died of other causes. We offer additional information to assist veterinarians, veterinary pathologists, and civic officials in identifying the probable cause of death for cat carcasses provided by members of the public.


Assuntos
Bem-Estar do Animal , Gatos , Coiotes , Patologia Legal , Patologia Veterinária , Alberta , Animais , Feminino , Masculino , Comportamento Predatório
4.
Artigo em Inglês | MEDLINE | ID: mdl-25679739

RESUMO

We present a sparse matrix permutation from graph theory that gives stable incomplete lower-upper preconditioners necessary for iterative solutions to the steady-state density matrix for quantum optomechanical systems. This reordering is efficient, adding little overhead to the computation, and results in a marked reduction in both memory and runtime requirements compared to other solution methods, with performance gains increasing with system size. Either of these benchmarks can be tuned via the preconditioner accuracy and solution tolerance. This reordering optimizes the condition number of the approximate inverse and is the only method found to be stable at large Hilbert space dimensions. This allows for steady-state solutions to otherwise intractable quantum optomechanical systems.

5.
Oncol Res ; 19(6): 287-95, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21776824

RESUMO

Bone metastases in advanced breast cancer patients remains a significant treatment challenge. Bisphosphonates are now a routine first line treatment for prevention and treatment of skeletal damage caused by malignancies and, moreover, have shown an ability to transport therapeutic drugs to the bone. Here, we describe the effect of a conjugate between the potent anticancer drug gemcitabine and a bisphosphonate molecule (Gem/BP) in an animal model of breast cancer metastases. We have previously demonstrated the targeting of this compound to bone in normal mice using an analog labeled with the radionuclide 99mTc. Using a bone metastasis model in nude mice produced by intracardiac injection of the human breast cancer cell line MDA-MB-231BO, we examined the effect of Gem/BP and gemcitabine in reducing the frequency and severity of osteolytic bone lesions. High-resolution radiographs and microPET images showed that Gem/ BP reduced the number and size of bone metastases relative to the gemcitabine-treated and the untreated control groups. Histological examination of the humeri and femurs of the control and gemcitabine groups revealed large metastatic cancer lesions in the outer and inner cortices and the medullary cavities. In contrast, Gem/BP-treated mice showed occasional small wedge-shaped metastases under the periosteum of the outer cortex and very occasionally in the medulla. These findings suggest that Gem/BP should be further evaluated for use in the treatment of bone metastases in breast cancer.


Assuntos
Antimetabólitos Antineoplásicos/administração & dosagem , Neoplasias Ósseas/tratamento farmacológico , Neoplasias da Mama/tratamento farmacológico , Desoxicitidina/análogos & derivados , Difosfonatos/administração & dosagem , Modelos Animais de Doenças , Animais , Antimetabólitos Antineoplásicos/química , Neoplasias Ósseas/diagnóstico por imagem , Neoplasias Ósseas/secundário , Neoplasias da Mama/diagnóstico por imagem , Neoplasias da Mama/patologia , Cálcio/sangue , Creatinina/sangue , Desoxicitidina/administração & dosagem , Desoxicitidina/química , Difosfonatos/química , Sistemas de Liberação de Medicamentos , Feminino , Humanos , Injeções Intralesionais , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Nus , Tomografia por Emissão de Pósitrons , Tecnécio , Células Tumorais Cultivadas , Gencitabina
6.
Phys Rev Lett ; 103(8): 087004, 2009 Aug 21.
Artigo em Inglês | MEDLINE | ID: mdl-19792751

RESUMO

We propose the use of a superconducting transmission line formed from an array of direct-current superconducting quantum interference devices for investigating analogue Hawking radiation. Biasing the array with a space-time varying flux modifies the propagation velocity of the transmission line, leading to an effective metric with a horizon. Being a fundamentally quantum mechanical device, this setup allows for investigations of quantum effects such as backreaction and analogue space-time fluctuations on the Hawking process.

7.
Vet Pathol ; 45(6): 941-4, 2008 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-18984801

RESUMO

Animal models are useful tools to study etiology, progress, and new treatments of disease and are an approximation of human disease for experimental study. Intracardiac injection of the human estrogen-independent breast cancer cell line MDA-MB-231 in nude mice is a well-characterized animal model of bone metastasis mainly used to study new treatments for late-stage breast cancer. According to the published literature, this model should produce radiologically distinguishable bone tumors within 17 days after injection. Mice should develop complications such as cachexia, paraplegia, and morbidity within 28 days and require euthanasia within 35 days after injection. We report a study in which injection of MDA-MB-231 cell line led to brain rather than bone metastasis. Unexpected alterations in biological behavior are an important confounding variable in the use of tumor cell lines, and the occurrence and cause of such variants is poorly documented.


Assuntos
Neoplasias Encefálicas/secundário , Neoplasias da Mama/patologia , Animais , Linhagem Celular Tumoral , Modelos Animais de Doenças , Humanos , Camundongos , Camundongos Nus , Metástase Neoplásica , Transplante de Neoplasias
8.
Int J Toxicol ; 27(3): 287-93, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18569170

RESUMO

Sodium hydrosulfide and dimethylsulfide duplicate the effects of hydrogen sulfide in causing coma in Sprague-Dawley rats and are additive for lethality. Nitrite, pyruvate and dithiothreitol had no significant effect on coma or lethality but bicarbonate with and without glucose reduced duration of coma. This finding suggests an antidotal treatment.


Assuntos
Coma/induzido quimicamente , Coma/tratamento farmacológico , Modelos Animais de Doenças , Sulfetos/toxicidade , Animais , Masculino , Ratos , Ratos Sprague-Dawley
9.
J Am Coll Cardiol ; 38(5): 1340-7, 2001 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-11691505

RESUMO

OBJECTIVES: The primary objective of this research was to assess the activation level of circulating monocytes in patients with unstable angina. BACKGROUND: Markers of systemic inflammatory responses are increased in patients with unstable coronary syndromes, but the activation state and invasive capacity of circulating monocytes have not been directly assessed. METHODS: Peripheral blood mononuclear cell (MC) activation in blood samples isolated from patients with stable and unstable coronary artery disease was measured in two studies. In study 1, a modified Boyden chamber assay was used to assess spontaneous cellular migration rates. In study 2, optical analysis of MC membrane fluidity was correlated with soluble CD14 (sCD14), a cellular activation marker. RESULTS: Increased rates of spontaneous monocyte migration (p < 0.01) were detected in patients with unstable angina (UA) (Canadian Cardiovascular Society [CCS] angina class IV) on comparison to patients with acute myocardial infarction (MI), stable angina (CCS angina classes I to III) or normal donors. No significant increase in lymphocyte migration was detected in any patient category. Baseline MC membrane fluidity measurements and sCD14 levels in patients with CCS class IV angina were significantly increased on comparison with MCs from normal volunteers (p < 0.001). A concomitant reduction in the MC response to activation was detected (p < 0.05). CONCLUSIONS: Using two complementary assays, activated monocytes with increased invasive capacity were detected in the circulation of patients with unstable angina. This is the first demonstration of increased monocyte invasive potential in unstable patients, raising the issue that systemic inflammation may both reflect and potentially drive plaque instability.


Assuntos
Angina Instável/sangue , Angina Instável/imunologia , Ativação Linfocitária/imunologia , Monócitos/imunologia , Análise de Variância , Angina Instável/classificação , Angina Instável/tratamento farmacológico , Biomarcadores/sangue , Estudos de Casos e Controles , Membrana Celular/imunologia , Movimento Celular/imunologia , Quimiotaxia de Leucócito/imunologia , Humanos , Imuno-Histoquímica , Inflamação , Receptores de Lipopolissacarídeos/sangue , Receptores de Lipopolissacarídeos/imunologia , Fluidez de Membrana/imunologia , Infarto do Miocárdio/sangue , Infarto do Miocárdio/imunologia , Índice de Gravidade de Doença
10.
J Infect Dis ; 183(3): 435-43, 2001 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-11133375

RESUMO

The Shiga toxins Stx1 and Stx2 contribute to the development of enterohemorrhagic O157:H7 Escherichia coli-mediated colitis and hemolytic-uremic syndrome in humans. The Stx2 B subunit, which binds to globotriaosylceramide (GB3) receptors on target cells, was cloned. This involved replacing the Stx2 B subunit leader peptide nucleotide sequences with those from the Stx1 B subunit. The construct was expressed in the TOPP3 E. coli strain. The Stx2 B subunits from this strain assembled into a pentamer and bound to a GB3 receptor analogue. The cloned Stx2 B subunit was not cytotoxic to Vero cells or apoptogenic in Burkitt's lymphoma cells. Although their immune response to the Stx2 B subunit was variable, rabbits that developed Stx2 B subunit-specific antibodies, as determined by immunoblot and in vitro cytotoxicity neutralization assays, survived a challenge with Stx2 holotoxin. This is thought to be the first demonstration of the immunoprophylactic potential of the Stx2 B subunit.


Assuntos
Infecções por Escherichia coli/prevenção & controle , Escherichia coli O157/imunologia , Vacinas contra Escherichia coli/imunologia , Toxina Shiga II/genética , Toxina Shiga II/imunologia , Animais , Anticorpos Antibacterianos/sangue , Apoptose , Linfoma de Burkitt , Chlorocebus aethiops , Clonagem Molecular/métodos , Ensaio de Imunoadsorção Enzimática , Infecções por Escherichia coli/virologia , Escherichia coli O157/metabolismo , Glicosídeos/toxicidade , Imunização , Testes de Neutralização , Plasmídeos/genética , Coelhos , Proteínas Recombinantes/genética , Proteínas Recombinantes/isolamento & purificação , Proteínas Recombinantes/toxicidade , Toxina Shiga II/metabolismo , Toxina Shiga II/toxicidade , Triterpenos/toxicidade , Células Tumorais Cultivadas , Células Vero
11.
Circulation ; 101(13): 1598-605, 2000 Apr 04.
Artigo em Inglês | MEDLINE | ID: mdl-10747355

RESUMO

BACKGROUND: Transplant vasculopathy remains a difficult therapeutic problem, resulting in the majority of late cardiac graft losses. This chronic vascular disease is thought to be triggered by alloantigen-dependent and alloantigen-independent inflammatory factors. Despite improved 1-year survival, the incidence of transplant vasculopathy has not improved with current immunosuppressive protocols. Highly effective strategies have evolved in the large DNA viruses that shield infecting viruses from host inflammatory responses. Serp-1 is a secreted myxoma virus anti-inflammatory serine proteinase inhibitor. Serp-1 inhibits plasminogen activators in a manner similar to plasminogen activator inhibitor (PAI-1), a vascular protein that plays a pivotal regulatory role in vascular wound healing. In this study, we tested the ability of purified Serp-1 protein to ameliorate posttransplant vasculopathy after rat aortic allograft surgery. METHODS AND RESULTS: Serp-1 protein or controls were infused into 98 rats immediately after segmental aortic allograft transplantation. After either late (28 days, 64 rats) or early (12 to 48 hours, 24 rats) follow-up, transplanted aortic segments were harvested for morphological and immunohistochemical analysis. Significant reductions in intimal plaque growth (P<0.002) and mononuclear cell invasion (P<0.033) were detected after Serp-1 infusion at nanogram doses. Serp-1 reduced early macrophage (P<0.0016) and nonspecific lymphocyte (P<0.0179) invasion into medial and adventitial layers and inhibited associated depletion of medial smooth muscle cells (P<0.0006). CONCLUSIONS: Infusion of a viral anti-inflammatory serpin, Serp-1, significantly reduces early inflammatory responses and later luminal occlusion in a rat aortic allograft model.


Assuntos
Anti-Inflamatórios/farmacologia , Aorta/transplante , Doenças da Aorta/prevenção & controle , Complicações Pós-Operatórias/prevenção & controle , Serpinas/farmacologia , Proteínas Virais/farmacologia , Animais , Aorta/patologia , Hiperplasia , Injeções Intravenosas , Linfócitos/patologia , Macrófagos/patologia , Monócitos/patologia , Ratos , Ratos Endogâmicos Lew , Ratos Sprague-Dawley , Túnica Íntima/patologia
12.
Lasers Surg Med ; 24(5): 346-59, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-10406475

RESUMO

BACKGROUND AND OBJECTIVE: Transplant vasculopathy is a leading cause of late cardiac graft loss. We have examined laser-induced fluorescence (LIF) spectroscopy as an optical diagnostic tool for detection of intimal plaque development and inflammatory cellular invasion in a rat model of aortic allograft transplant. STUDY DESIGN/MATERIALS AND METHODS: Infrarenal aortic segments were transplanted from Lewis to Sprague Dawley rats. A range of vasculopathy development was produced by treatment with a viral anti-inflammatory protein. LIF spectra were recorded from the intima of aortic implants at 28 days. Fluorescence intensity was analyzed for correlation with vasculopathy development. RESULTS: Significant differences in LIF intensity at 400-450 nm (P < or = 0.05 by ANOVA) were detected. LIF emission was correlated with plaque growth (R2 = 0.980), vessel narrowing (R2 = 0.964), and cellular invasion (R2 = 0.971) by regression analysis. CONCLUSION: LIF optical analysis provides a nontraumatic diagnostic approach for detection of atherosclerosis prior to cardiac transplant or during development of vasculopathy after transplant.


Assuntos
Aorta Abdominal/transplante , Arteriosclerose/diagnóstico , Complicações Pós-Operatórias/diagnóstico , Animais , Microscopia Confocal , Ratos , Ratos Endogâmicos Lew , Ratos Sprague-Dawley
13.
Am J Physiol ; 276(5): G1165-73, 1999 05.
Artigo em Inglês | MEDLINE | ID: mdl-10330007

RESUMO

In alpha-naphthylisothiocyanate-treated mice, plasma phospholipid (PL) levels were elevated 10- and 13-fold at 48 and 168 h, respectively, whereas free cholesterol (FC) levels increased between 48 h (17-fold) and 168 h (39-fold). Nearly all of these lipids were localized to lipoprotein X-like particles in the low-density lipoprotein density range. The PL fatty acyl composition was indicative of biliary origin. Liver cholesterol and PL content were near normal at all time points. Hepatic hydroxymethylglutaryl CoA reductase activity was increased sixfold at 48 h, and cholesterol 7alpha-hydroxylase activity was decreased by approximately 70% between 24 and 72 h. These findings suggest a metabolic basis for the appearance of abnormal plasma lipoproteins during cholestasis. Initially, PL and bile acids appear in plasma where they serve to promote the efflux of cholesterol from hepatic cell membranes. Hepatic cholesterol synthesis is then likely stimulated in the response to the depletion of hepatic cell membranes of cholesterol. We speculate that the enhanced synthesis of cholesterol and impaired conversion to bile acids, particularly during the early phase of drug response, contribute to the accumulation of FC in the plasma.


Assuntos
1-Naftilisotiocianato , Colestase/sangue , Colestase/induzido quimicamente , Colesterol/biossíntese , Colesterol/sangue , Fígado/metabolismo , Animais , Bile/química , Ácidos e Sais Biliares/sangue , Ácidos e Sais Biliares/metabolismo , Bilirrubina/sangue , Colestase/patologia , Colesterol 7-alfa-Hidroxilase/metabolismo , Feminino , Vesícula Biliar/metabolismo , Hidroximetilglutaril-CoA Redutases/metabolismo , Lipídeos/análise , Lipídeos/sangue , Lipoproteínas/sangue , Fígado/química , Fígado/patologia , Camundongos , Camundongos Endogâmicos C57BL , Fosfolipídeos/sangue
15.
Can Vet J ; 40(2): 113-7, 1999 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-10065319

RESUMO

This report describes and discusses the history, clinical, pathologic, epidemiologic, and human health aspects of an outbreak of Mycobacterium bovis infection in domestic wapiti in Alberta between 1990 and 1993, shortly after legislative changes allowing game farming. The extent and seriousness of the outbreak of M. bovis in wapiti in Alberta was not fully known at its onset. The clinical findings in the first recognized infected wapiti are presented and the postmortem records for the herd in which the animal resided are summarized. Epidemiologic findings from the subsequent field investigation are reviewed, the results of recognition and investigation of human exposure are updated, and recommendations for reduction of human exposure are presented.


Assuntos
Cervos , Surtos de Doenças/veterinária , Mycobacterium bovis , Tuberculose/veterinária , Alberta/epidemiologia , Animais , Humanos , Indústria de Embalagem de Carne , Exposição Ocupacional , Teste Tuberculínico , Tuberculose/epidemiologia , Médicos Veterinários
16.
Cardiovasc Res ; 38(1): 237-46, 1998 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-9683927

RESUMO

OBJECTIVES: Accelerated atherosclerosis is associated with herpesviral infection both in transplant patients and after balloon angioplasty. Marek's disease virus (MDV) is a herpesvirus that induces accelerated atherosclerosis associated with the development of an invasive lymphoma in hyperlipemic roosters. We have examined the effects of pravastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A (HMGCoA) reductase inhibitor and quinapril, an angiotensin converting enzyme (ACE) inhibitor, on atherosclerosis development in MDV infected, cholesterol fed rooster chicks. METHODS: The effects of these drugs on plaque growth after MDV infection were examined in two studies. In Study 1, MDV infected White Leghorn rooster chicks were divided into 4 groups assigned to normal or high cholesterol diet, and treated at three months of age with either pravastatin or saline. In Study 2, cholesterol fed rooster chicks infected with MDV were divided into 3 groups for treatment with either pravastatin, quinapril, or saline control. RESULTS: A significant decrease in plaque area was detected after 60 days of treatment with both pravastatin and quinapril in cholesterol fed chicks (P < 0.001). Lymphocyte infiltration into the arterial wall or target organs was not inhibited by treatment with either drug. CONCLUSIONS: (1) HMGCoA reductase inhibitor and ACE inhibitor therapy reduce atherosclerosis induced by virus infection and cholesterol diet, but this decrease in plaque growth is not due to a reduction in lymphocyte invasion. (2) MDV infection in cholesterol fed roosters provides a model for virus-induced arterial injury in atherogenesis.


Assuntos
Inibidores da Enzima Conversora de Angiotensina/uso terapêutico , Arteriosclerose/tratamento farmacológico , Inibidores de Hidroximetilglutaril-CoA Redutases/uso terapêutico , Hipercolesterolemia/complicações , Pravastatina/uso terapêutico , Tetra-Hidroisoquinolinas , Animais , Arteriosclerose/complicações , Arteriosclerose/imunologia , Arteriosclerose/virologia , Artérias Carótidas/imunologia , Artérias Carótidas/patologia , Galinhas , Colesterol/sangue , Modelos Animais de Doenças , Herpesvirus Galináceo 2 , Hipercolesterolemia/tratamento farmacológico , Isoquinolinas/uso terapêutico , Linfócitos/imunologia , Doença de Marek/complicações , Doença de Marek/imunologia , Quinapril
17.
Can J Vet Res ; 61(3): 187-92, 1997 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-9242998

RESUMO

Twenty four (24) healthy male Holstein calves (< 70 kg) were each experimentally infected by intrabronchial inoculation of 4.0 x 10(9) viable cells of Pasteurella haemolytica-AI (B122) at Time = 0 h. At 1 h following inoculation animals received either: 1) Sham treatment with sterile 0.85% saline SC (n = 12); or 2) a single injection of 10 mg tilmicosin per kg body weight (n = 12). Calves that were non-infected and tilmicosin-treated were also included for determining tilmicosin concentrations in serum and lung tissue at 1, 2, 4, 6, 8, 24, 48, and 72 h (n = 3-per time). In the infected calves, response to therapy was monitored clinically. Serum samples were collected for determination of tilmicosin concentrations using HPLC. Any animal becoming seriously ill was humanely killed. Complete necropsy examinations were performed on all animals and included gross pathologic changes, bacteriologic analysis, histopathology, and determination of pulmonary concentrations of tilmicosin. Tilmicosin treated animals responded significantly better to therapy than saline-treated control calves. Clinical assessment of calves during the study indicated that tilmicosin-treated calves had significantly improved by T = 8 h compared to satine-treated animals (P < 0.05). At necropsy tilmicosin-treated calves had significantly less severe gross and histological lesions (P < 0.05) of the pulmonary tissue. Of the 12 saline-treated calves, 92% (11/12) had Pasteurella haemolytica-A1 in lung tissue, while of the tilmicosin-treated calves 0% (0/12) cultured positive for P. haemolytica. Mean (+/- standard error) serum tilmicosin concentrations in infected calves peaked at 1 h post-injection (1.10 +/- 0.06 micrograms/mL) and rapidly decreased to 0.20 +/- 0.03 microgram/mL, well below the MIC of 0.50 microgram/mL for P. haemolytica-A1 (B122), by 12 h. These serum concentrations were very similar to serum concentrations of tilmicosin in non-infected tilmicosin-treated calves. Lung tissue concentrations of the antibiotic were comparatively high, even at 72 h post-infection (6.50 +/- 0.75 ppm). Lung tissue concentrations at 72 h were significantly higher in experimentally infected calves than in non-infected tilmicosin-treated animals (P < 0.05). These data demonstrate that tilmicosin was effective in treating experimentally-induced pneumonic pasteurellosis as determined by alleviation of clinical signs, pathological findings at post mortem, and presence of viable bacteria from the lung. Concentrations substantially above MIC for P. haemolytica were present in lung tissue even at 72 h following a single subcutaneous injection of 10 mg tilmicosin per kg body weight.


Assuntos
Antibacterianos , Macrolídeos , Mannheimia haemolytica , Pasteurelose Pneumônica/tratamento farmacológico , Tilosina/análogos & derivados , Animais , Bovinos , Doenças dos Bovinos/patologia , Cromatografia Líquida de Alta Pressão/métodos , Cromatografia Líquida de Alta Pressão/veterinária , Relação Dose-Resposta a Droga , Hemorragia/patologia , Hemorragia/veterinária , Pulmão/química , Pulmão/microbiologia , Pulmão/patologia , Masculino , Mannheimia haemolytica/isolamento & purificação , Pasteurelose Pneumônica/etiologia , Pasteurelose Pneumônica/patologia , Distribuição Aleatória , Fatores de Tempo , Tilosina/análise , Tilosina/sangue , Tilosina/uso terapêutico
18.
J Immunol Methods ; 202(1): 49-57, 1997 Mar 10.
Artigo em Inglês | MEDLINE | ID: mdl-9075771

RESUMO

This study examines the intranasal instillation of lipopolysaccharide (LPS) into BALB/c mice causing acute pulmonary damage, due to neutrophil infiltration and sepsis. A dose response with LPS showed that an intranasal instillation of 167 microg/ml (10 microg/mouse) caused acute lung injury within 2-4 h and reached maximal damage at 24-48 h. We found the method of LPS administration for induction of acute pulmonary damage to be crucial. After 24 h post-LPS injection, a comparison showed a substantial increase in pulmonary damage with intranasal instillation of LPS. As for intravenous injection, it showed a baseline effect. This study indicates that LPS administered intranasally causes acute pulmonary damage, whereas with intravenous and intraperitoneal endotoxin administration a tissue-specific or similar degree of pulmonary injury may not develop.


Assuntos
Infecções por Escherichia coli/patologia , Lipopolissacarídeos/administração & dosagem , Lipopolissacarídeos/toxicidade , Pneumopatias/patologia , Infecções por Pseudomonas/patologia , Doença Aguda , Administração Intranasal , Animais , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Infecções por Escherichia coli/induzido quimicamente , Feminino , Injeções Intravenosas , Pneumopatias/induzido quimicamente , Camundongos , Camundongos Endogâmicos BALB C , Infecções por Pseudomonas/induzido quimicamente
19.
Toxicol In Vitro ; 11(5): 633-6, 1997 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20654362

RESUMO

Rhodamine B has been used as a histopathological stain for keratinization and cornification. Its ability as an in vitro indicator of the degree of epidermal keratinization was investigated in these preliminary studies. An immortalized human keratinocyte cell line, SVK-14, was evaluated as an alternative to primary human keratinocytes. The influence of extracellular calcium levels was evaluated alongside the effects of exposure to 1,25 (OH)(2) vitamin D(3) in serum-free and serum-containing media. Alamar blue (AB) conversion was used to measure changes in cellular reductive potential, and the amount of bound Rhodamine B relative to total protein per well was taken as an indicator of keratinization. Exposure to 1,25 (OH)(2) vitamin D(3) for 7 or 10 days did not increase Rhodamine B binding to confluent SVK-14 cultures, regardless of calcium concentration. Variation in Rhodamine B dye-binding to cells made it difficult to interpret the data. In addition, concern regarding the ability of SVK-14 cells to differentiate suggests that further studies need to be performed using normal human keratinocytes to validate this in vitro endpoint, with epidermal growth factor, insulin and hydrocortisone removed from the media to enhance epidermal differentiation.

20.
Circulation ; 94(11): 2890-900, 1996 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-8941118

RESUMO

BACKGROUND: Recurrent atherosclerotic plaque growth, restenosis, is a significant clinical problem after interventional procedures. Initiation of restenosis involves activation of inflammatory and thrombotic cascades, which are regulated by serine proteinase enzymes and inhibitors. We have investigated the use of a viral serine proteinase inhibitor, SERP-1, to reduce plaque development after primary balloon angioplasty. This is the first experimental report of the use of a viral anti-inflammatory protein for the prevention of atherosclerosis. METHODS AND RESULTS: Seventy-four cholesterol-fed rabbits were treated with either local or systemic infusions of SERP-1 protein (or control solutions) after balloon-mediated injury. Sites of SERP-1 infusion in rabbits had dramatically reduced plaque compared with control infusions at the 4-week follow-up. At low-dose infusions (30 to 300 pg), only the primary infusion site had a demonstrable decrease in plaque, whereas at higher-dose infusions (> 3000 pg), a generalized reduction in plaque development was detected. An associated decrease in mononuclear cell infiltration of the arterial wall was detected after SERP-1 infusion within the first 24 hours. Infusion of an active-site mutant of SERP-1 (P1-P1', ala-ala) lacking serine proteinase inhibitory activity failed to prevent plaque growth. CONCLUSIONS: Purified SERP-1, a virus-encoded secreted glycoprotein, reduces plaque growth after primary balloon-mediated injury. Plaque development is decreased by inhibition of serine proteinase activity and is associated with a focal reduction in macrophage infiltration immediately after injury. Investigation of serine proteinase inhibitors may provide new insight into the regulation of arterial responses to injury.


Assuntos
Angioplastia com Balão , Arteriosclerose/prevenção & controle , Inibidores de Serina Proteinase/farmacologia , Serpinas/farmacologia , Proteínas Virais/farmacologia , Animais , Arteriosclerose/etiologia , Arteriosclerose/patologia , Coagulação Sanguínea/efeitos dos fármacos , Movimento Celular , Colesterol/sangue , Relação Dose-Resposta a Droga , Injeções Intra-Arteriais , Injeções Intravenosas , Macrófagos/patologia , Macrófagos/fisiologia , Mutação , Coelhos , Serpinas/efeitos adversos , Serpinas/genética , Proteínas Virais/efeitos adversos , Proteínas Virais/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...